A national study finds technology use and blood sugar control are up in youths and adults with type 1 diabetes, yet racial, ...

An expert discusses how ITP treatment success is monitored through maintaining safe platelet levels and symptom control, ...

Clayton Irvine, PharmD, MBA, MS, discusses strategies to address payer-driven biosimilar and prior authorization challenges through integrated digital solutions, while advocating for flexible, ...

Elise S. Tremblay, MD, MPH, explores potential policy solutions and research directions to address ongoing challenges in insulin affordability and access.

The analysis highlighted a shift in heart failure diagnoses, with hypertensive heart disease with and without chronic kidney disease as prevalent diagnoses, underlining coding variability and ...

An expert discusses the importance of balancing efficacy with safety in ITP treatment, emphasizing cautious use of steroids, close monitoring of therapy-related side effects, and maintaining platelet ...

Hair and scalp disorders in patients with skin of color are frequently misdiagnosed, often due to educational gaps and ...

DYNE-251 received FDA breakthrough therapy designation, showcasing its potential for patients with Duchenne muscular ...

Individuals who used smokeless tobacco and e-cigarettes had an increased risk of developing age-related macular degeneration ...

Physicians were more likely to include terms that undermine the competence and sincerity of Black patients' claims when ...

More than 8 in 10 patients with rheumatoid arthritis were taking 5 or more medications at once, a practice linked to older ...

The clearance rates for those coinfected with HIV and hepatitis C virus (HCV) are still higher than those with HCV alone.